Steendam CMJ, Peric R, van Walree NC, Youssef M, et al. Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma. Lung Cancer 2021;160:44-49.
PMID: 34403911